Business Brief -- A.L. Laboratories Inc.:
   Net Loss of $5.7 Million
   Is Posted for 4th Quarter
The company, which is 50%-owned by Norway's Apothekernes
Laboratorium AS, took a charge of $13 million for costs of
meeting tougher Food and Drug Administration requirements for
making pharmaceuticals, as well as employee termination costs
related to compliance with the new regulations. A.L. Labs
previously said the charge would be about $11 million.
   For the year, profit fell sharply to $5.1 million, or 30
cents a share, from $14.1 million, or 84 cents a share.
Revenue rose 7.1% to $295 million from $275.5 million.
   In late New York Stock Exchange trading yesterday, A.L.
Labs shares fell 37.5 cents to $22.